Michael Falci
Podiatrist · York, PANPI 1669858114
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Arthrex at 44.1% of the total. Among podiatrist clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $104.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Novus Surgical Consultants$3K
- Paragon 28, Inc.$1K
- Novus Surgical Solutions LLC$400
- Treace Medical Concepts, Inc.$253
- Smith+Nephew$80
- plus $166 from 6 others
What the payments were for
- Travel & lodging$4,92057%
- Food & beverage$2,34527%
- Education$1,37516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 31 | $3,808 |
| Novus Surgical Consultants | 19 | $2,505 |
| Paragon 28, Inc. | 13 | $1,428 |
| Novus Surgical Solutions LLC | 1 | $400 |
| Treace Medical Concepts, Inc. | 9 | $253 |
| Smith+Nephew | 2 | $80 |
| Stryker | 2 | $37 |
| Integra Lifesciences Corporation | 1 | $34 |
| Johnson & Johnson | 1 | $31 |
| Globus Medical | 2 | $28 |
| Urgo Medical North America, LLC | 1 | $20 |
| KCI USA, Inc. | 1 | $17 |
How this compares
$8,640 in reported general payments places this provider in the 90th percentile of 445 podiatrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 18 | $674 |
| Ciclopirox | 23 | $476 |
| Terbinafine Hcl | 44 | $378 |
| Methylprednisolone | 51 | $344 |
| Doxycycline Hyclate | 67 | $323 |
| CefuroximeCefuroxime Axetil | 34 | $310 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $206 |
| Ammonium Lactate | 15 | $196 |
| Meloxicam | 60 | $194 |
| SsdSilver Sulfadiazine | 21 | $161 |
| Silver Sulfadiazine | 29 | $143 |
| Gabapentin | 21 | $125 |
| Oxycodone Hcl | 28 | $115 |
| Diclofenac Sodium | 14 | $108 |
| Prednisone | 14 | $22 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in York
- John LapelusaYork$54K
- Samuel ClellenYork$29K
- Rachel WarnerYork$26K
- Rahim LakhaniYork$21K
- Sonam RuitYork$7K
- Mark HofbauerBelle Vernon$1.1M
- Daniel PerezPhiladelphia$434K
- Christopher BarrettChester$229K
- Alan CatanzaritiPittsburgh$80K
- John StarinskiPen Argyl$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.